University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Items where Author is "de Bono, J"

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 9.


Ang, JE, Pal, A, Asad, YJ, Henley, AT, Valenti, M, Box, G, de haven Brandon, A, Revell, Victoria, Skene, Debra, Venturi, M, Rueger, R, Meresse, V, Eccles, SA, de Bono, JS, Kaye, SB, Workman, P, Banerji, U and Raynaud, FI (2017) Modulation of plasma metabolite biomarkers of MAPK pathway with the MEK inhibitor RO4987655: pharmacodynamic and predictive potential in metastatic melanoma. Molecular Cancer Therapeutics.

Roulstone, V, Khan, K, Pandha, HS, Rudman, S, Coffey, M, Gill, GM, Melcher, AA, Vile, R, Harrington, KJ, de Bono, J and Spicer, J (2015) Phase I Trial of Cyclophosphamide as an Immune Modulator for Optimizing Oncolytic Reovirus Delivery to Solid Tumors CLINICAL CANCER RESEARCH, 21 (6). pp. 1305-1312.

de Bono, JS, Piulats, JM, Pandha, HS, Petrylak, DP, Saad, F, Aparicio, LMA, Sandhu, SK, Fong, P, Gillessen, S, Hudes, GR, Wang, T, Scranton, J and Pollak, MN (2014) Phase II Randomized Study of Figitumumab plus Docetaxel and Docetaxel Alone with Crossover for Metastatic Castration-Resistant Prostate Cancer CLINICAL CANCER RESEARCH, 20 (7). pp. 1925-1934.

Richards, J, Lim, AC, Hay, CW, Taylor, AE, Wingate, A, Nowakowska, K, Pezaro, C, Carreira, S, Goodall, J, Arlt, W, McEwan, IJ, de Bono, JS and Attard, G (2012) Interactions of Abiraterone, Eplerenone, and Prednisolone with Wild-type and Mutant Androgen Receptor: A Rationale for Increasing Abiraterone Exposure or Combining with MDV3100 CANCER RESEARCH, 72 (9). pp. 2176-2182.

Attard, G, Richards, J and de Bono, JS (2011) New Strategies in Metastatic Prostate Cancer: Targeting the Androgen Receptor Signaling Pathway CLINICAL CANCER RESEARCH, 17 (7). pp. 1649-1657.

Yap, TA, Brunetto, A, Pandha, H, Harrington, K and de Bono, JS (2008) Reovirus therapy in cancer: has the orphan virus found a home? EXPERT OPINION ON INVESTIGATIONAL DRUGS, 17 (12). pp. 1925-1935.

Errington, F, Steele, L, Prestwich, R, Harrington, KJ, Pandha, HS, Vidal, L, de Bono, J, Selby, P, Coffey, M, Vile, R and Melcher, A (2008) Reovirus activates human dendritic cells to promote innate antitumor immunity JOURNAL OF IMMUNOLOGY, 180 (9). pp. 6018-6026.

Qiao, J, Wang, H, Kottke, T, White, C, Twigger, K, Diaz, RM, Thompson, J, Selby, P, de Bono, J, Melcher, A, Pandha, H, Coffey, M, Vile, R and Harrington, K (2008) Cyclophosphamide facilitates antitumor efficacy against subcutaneous tumors following intravenous delivery of reovirus CLINICAL CANCER RESEARCH, 14 (1). pp. 259-269.

Conference or Workshop Item

Karapanagiotou, E, Pandha, HS, Hall, G, Chester, J, Melcher, A, Coffey, M, de Bono, J, Gore, ME, Nutting, CM and Harrington, KJ (2009) Phase I/II trial of oncolytic reovirus (Reolysin) in combination with carboplatin/paclitaxel in patients (pts) with advanced solid cancers In: 45th Annual Meeting of the American-Society-of-Clinical-Oncology, 2009-05-29 - 2009-06-02, Orlando, FL.

This list was generated on Wed Jun 3 20:04:13 2020 UTC.

Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800